Merck Settles with Victims of Deadly Drug Vioxx

Text Size

Merck Settles with Victims of Deadly Drug Vioxx 

For Immediate Release: November 9, 2007

AAJ Communications
202.965.3500, x369

Washington, DC—American Association for Justice (AAJ) CEO Jon Haber made the following statement today, following the announcement that an agreement between drugmaker Merck and attorneys for thousands of Vioxx victims has been reached:

From 1999 to 2004, when it was pulled from the market, Merck sold $11 billion of Vioxx around the world to people who were purposefully kept unaware of the drug’s dangers. According to Food and Drug Administration scientist Dr. David Graham, the drug contributed to as many as 139,000 heart attacks and as many as 55,000 deaths in the United States.

American Association for Justice attorneys fought ceaselessly for this result – initiating the first suits, being the driving force to uncover Merck's misconduct and negligence and leading the litigation nationwide. These attorneys took on a powerful multi-billion dollar corporation, holding them accountable for producing an unsafe product. The attorneys in the multi-district litigation and coordinated state court proceedings all deserve our thanks and congratulations for their tireless efforts.

As the world's largest trial bar, the American Association for Justice (formerly known as the Association of Trial Lawyers of America) works to make sure people have a fair chance to receive justice through the legal system when they are injured by the negligence or misconduct of others—even when it means taking on the most powerful corporations. Visit

The American Association for Justice
777 6th Street, NW, Ste 200 • Washington, DC  20001 • 800.424.2725 or 202.965.3500

© 2014 AAJ